Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01997502 · ClinicalTrials.gov registry record
Accuracy of Pulse CO-Oximetry Technology in Characterizing Noninvasive SpHb
A clinical trial of Surgery and Hemoglobin, sponsored by University of California, Davis.
- Completed
- Registry status
- 621
- Enrollment target
- 1
- Study location
NCT01997502: Completed study of Surgery and Hemoglobin, sponsored by University of California, Davis.
NCT01997502 is a study of Surgery and Hemoglobin that has completed, run by University of California, Davis. The registered enrollment target is 621 participants, below the 52,847-participant average among 120 other Surgery trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01997502, a study of Surgery and Hemoglobin, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 621 participants
- Enrollment target
- 1
- Study location
Study Summary
This protocol is a request from Masimo to assist in the collection of data to be used to further refine the accuracy of the monitor's algorithm.
Primary Outcome
Correlation between standard, lab-based, hemoglobin measurement and concurrent SpHb.
Conditions Studied
Interventions
- OTHER Blood draw
- DEVICE Pulse CO-Oximetry Technology
Study Locations (1)
California
- UC Davis Health - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 621 participants |
| Start Date | 2013-11-26 |
| Est. Completion | 2024-10-21 |
What the finished NCT01997502 record still lists
NCT01997502 is an observational study that tracks outcomes without assigning an intervention. The registered 621 participants enrollment target is mid-sized for trials with a published cap, below the 52,847-participant average among 120 other Surgery trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which Blood draw is the first listed.
NCT01997502 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01997502 about?
NCT01997502 is a clinical study titled "Accuracy of Pulse CO-Oximetry Technology in Characterizing Noninvasive SpHb". This protocol is a request from Masimo to assist in the collection of data to be used to further refine the accuracy of the monitor's algorithm.
What is the current status of trial NCT01997502?
This trial is currently completed. The enrollment target is 621 participants. The study started on 2013-11-26. Estimated completion is 2024-10-21.
What conditions does trial NCT01997502 study?
This clinical trial studies the following conditions: Surgery, Hemoglobin.
What interventions are being tested in trial NCT01997502?
The interventions under investigation include: Blood draw (OTHER), Pulse CO-Oximetry Technology (DEVICE).
Who is sponsoring clinical trial NCT01997502?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01997502 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01997502's enrollment target sits among peer trials
621 18th of 120 higher than 103 of 120 other Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Terumo Aortic Global Endovascular Registry
RECRUITING
-
A Study of the Use of 3D Technology to Guide Head and Neck Surgery
RECRUITING · NA
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
NO During CPB in Neonates to Reduce Risk of AKI
RECRUITING · Phase 3
-
INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients
RECRUITING · NA
-
Ultrasound Evaluation for Improving Patient Selection in vNOTES
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06712355 · 621 participants · Phase 3
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- NCT02282969 · 620 participants
PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
- NCT02838836 · 620 participants
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
- NCT05538910 · 620 participants · NA
Defining Neurobiological Links Between Substance Use and Mental Illness
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI